![1,3-Dihydro-1-[1-[(2S)-2-hydroxy-1-oxopropyl]-4-piperidinyl]-3-methyl-8-(6-methyl-3-pyridinyl)-2H-…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FFD111860.webp&w=3840&q=75)
1,3-Dihydro-1-[1-[(2S)-2-hydroxy-1-oxopropyl]-4-piperidinyl]-3-methyl-8-(6-methyl-3-pyridinyl)-2H-imidazo[4,5-c][1,5]naphthyridin-2- one
CAS:
Ref. 3D-FD111860
Información del producto
Nombre:1,3-Dihydro-1-[1-[(2S)-2-hydroxy-1-oxopropyl]-4-piperidinyl]-3-methyl-8-(6-methyl-3-pyridinyl)-2H-imidazo[4,5-c][1,5]naphthyridin-2- one
Marca:Biosynth
Descripción:Imatinib is a small molecule that inhibits the tyrosine kinase activity of the BCR-ABL protein. It is used in the treatment of chronic lymphocytic leukemia and certain types of cancers, such as skin cancer, chronic myelogenous leukemia, or gastrointestinal stromal tumors. Imatinib has been shown to inhibit the growth of tumor cells by blocking the epidermal growth factor receptor (EGFR) and blocking the activation of mitogen-activated protein kinases (MAPK). Imatinib also has anti-inflammatory effects by binding to all-trans-retinoic acid and inhibiting its conversion to retinol.
Aviso:Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Propiedades químicas
Peso molecular:446.5 g/mol
Fórmula:C24H26N6O3
Pureza:Min. 95%